AvenCell is based in Watertown, Massachusetts. It has raised $362M in total funding. Latest round: Series B.
AvenCell funding overview
AvenCell is based in Watertown, Massachusetts. AvenCell has raised $362M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in October 2024. The round record for AvenCell runs through 2024; nothing later has been disclosed. Investors on record include Blackstone Life Sciences, Novo Holdings, F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, NYBC Ventures. 6 distinct backers are named across the disclosed rounds.
AvenCell at a glance
Total raised
$362M
Latest round
Series B
Latest round date
October 2024
Headquarters
Watertown, Massachusetts
Notable investors
Blackstone Life Sciences, Novo Holdings, F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, NYBC Ventures
Frequently asked about AvenCell funding
How much has AvenCell raised?
AvenCell has raised $362M in total disclosed funding across the rounds on record.
Who has invested in AvenCell?
Blackstone Life Sciences, Novo Holdings, F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, NYBC Ventures are named among the investors backing AvenCell.
What was the latest AvenCell funding round?
The most recent disclosed round is a Series B, announced in October 2024.
Where is AvenCell based?
AvenCell is based in Watertown, Massachusetts.
When did AvenCell last raise?
The last disclosed AvenCell round closed in October 2024 at Series B.
AvenCell totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Watertown below to benchmark round size and investor mix.
